Why We Think Seach Medical Group Ltd's (TLV:SEMG) CEO Compensation Is Not Excessive At All
Jun 25
Have your own idea? Try our Stock Screener
Israeli (TA) Pharma Industry Analysis
UpdatedSep 28, 2025
DataAggregated Company Financials
Companies8
- 7D-2.3%
- 3M-12.5%
- 1Y-34.7%
- YTD-29.2%
Over the last 7 days, the Pharma industry has dropped 2.3%, driven by a pullback from InterCure of 4.1%. In contrast, Blue Wave Water Capital has gained 10%. However, the industry is down 35% over the past year.
Industry Valuation and Performance
Has the Israeli Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 28 Sep 2025 | ₪542.3m | ₪716.6m | -₪84,451,466.30 | 6.7x | -6.4x | 0.8x |
| Tue, 26 Aug 2025 | ₪578.8m | ₪716.7m | -₪67,050,263.50 | 28.6x | -8.6x | 0.8x |
| Thu, 24 Jul 2025 | ₪566.5m | ₪716.7m | -₪71,476,340.30 | 29.4x | -7.9x | 0.8x |
| Sat, 21 Jun 2025 | ₪585.9m | ₪716.7m | -₪72,075,817.80 | 32.9x | -8.1x | 0.8x |
| Mon, 19 May 2025 | ₪578.3m | ₪732.8m | -₪81,895,272.00 | 14.8x | -7.1x | 0.8x |
| Wed, 16 Apr 2025 | ₪557.4m | ₪766.6m | -₪80,760,764.00 | 14.3x | -6.9x | 0.7x |
| Fri, 14 Mar 2025 | ₪651.2m | ₪828.6m | -₪165,149,004.00 | 21.1x | -3.9x | 0.8x |
| Sun, 09 Feb 2025 | ₪680.6m | ₪828.6m | -₪180,138,925.40 | 21.5x | -3.8x | 0.8x |
| Tue, 07 Jan 2025 | ₪682.6m | ₪828.6m | -₪180,939,830.00 | 20.3x | -3.8x | 0.8x |
| Thu, 05 Dec 2024 | ₪611.3m | ₪828.6m | -₪180,755,633.60 | 20.6x | -3.4x | 0.7x |
| Sat, 02 Nov 2024 | ₪684.7m | ₪808.7m | -₪205,489,888.80 | 22.9x | -3.3x | 0.8x |
| Mon, 30 Sep 2024 | ₪670.0m | ₪808.7m | -₪205,231,789.70 | 22.6x | -3.3x | 0.8x |
| Wed, 28 Aug 2024 | ₪671.8m | ₪901.7m | -₪251,857,177.70 | n/a | -2.7x | 0.7x |
| Fri, 26 Jul 2024 | ₪727.4m | ₪901.7m | -₪262,027,564.80 | n/a | -2.8x | 0.8x |
| Sun, 23 Jun 2024 | ₪644.5m | ₪901.7m | -₪258,177,438.00 | n/a | -2.5x | 0.7x |
| Tue, 21 May 2024 | ₪862.0m | ₪886.2m | -₪260,231,980.00 | n/a | -3.3x | 1x |
| Thu, 18 Apr 2024 | ₪727.2m | ₪956.4m | -₪181,474,976.00 | 19.8x | -4x | 0.8x |
| Sat, 16 Mar 2024 | ₪641.6m | ₪972.3m | -₪208,598,012.00 | 14.2x | -3.1x | 0.7x |
| Mon, 12 Feb 2024 | ₪619.4m | ₪972.3m | -₪213,050,733.70 | 12.8x | -2.9x | 0.6x |
| Wed, 10 Jan 2024 | ₪578.5m | ₪972.3m | -₪214,223,943.00 | 11.3x | -2.7x | 0.6x |
| Fri, 08 Dec 2023 | ₪614.7m | ₪972.3m | -₪213,396,167.00 | 10.7x | -2.9x | 0.6x |
| Sun, 05 Nov 2023 | ₪573.2m | ₪958.8m | -₪211,988,622.00 | 8.6x | -2.7x | 0.6x |
| Tue, 03 Oct 2023 | ₪690.5m | ₪958.8m | -₪210,159,990.00 | 13.5x | -3.3x | 0.7x |
| Thu, 31 Aug 2023 | ₪649.4m | ₪920.2m | -₪192,672,929.00 | 8x | -3.4x | 0.7x |
| Sat, 29 Jul 2023 | ₪643.2m | ₪918.8m | -₪126,340,660.00 | 8.5x | -5.1x | 0.7x |
| Mon, 26 Jun 2023 | ₪726.4m | ₪918.8m | -₪125,074,076.00 | 9.8x | -5.8x | 0.8x |
| Wed, 24 May 2023 | ₪820.4m | ₪906.2m | -₪126,989,680.00 | 12.1x | -6.5x | 0.9x |
| Fri, 21 Apr 2023 | ₪815.2m | ₪855.1m | -₪87,341,033.00 | 9.6x | -9.3x | 1x |
| Sun, 19 Mar 2023 | ₪777.6m | ₪815.6m | -₪72,373,894.00 | 12x | -10.7x | 1x |
| Tue, 14 Feb 2023 | ₪1.0b | ₪815.6m | -₪69,026,188.00 | 16.6x | -14.7x | 1.2x |
| Thu, 12 Jan 2023 | ₪1.0b | ₪739.7m | -₪55,988,588.00 | 17.1x | -18x | 1.4x |
| Sat, 10 Dec 2022 | ₪1.2b | ₪739.7m | -₪55,862,263.00 | 21.5x | -21.1x | 1.6x |
| Mon, 07 Nov 2022 | ₪1.3b | ₪689.4m | -₪60,819,349.00 | 32.2x | -21.2x | 1.9x |
| Wed, 05 Oct 2022 | ₪1.3b | ₪689.4m | -₪60,832,323.00 | 31.5x | -21.3x | 1.9x |
Price to Earnings Ratio
-21.3x
Current Industry PE
- Investors are pessimistic on the Israeli Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading close to its 3-year average PS ratio of 0.89x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare industry?
| IL Market | 0.79% | |
| Healthcare | -1.29% | |
| Pharma | -2.26% | |
| Pharma | -2.26% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BLWV-M Blue Wave Water Capital | ₪2.37 | 10.2% +₪988.5k | 31.2% | PE-4.5x | |
| TKUN Tikun Olam-Cannbit Pharmaceuticals | ₪0.39 | 1.6% +₪509.8k | 18.2% | PS0.9x | |
| NXGN Nextgen Biomed | ₪0.57 | 1.8% +₪115.4k | -14.8% | PE-1.3x | |
| SEMG Seach Medical Group | ₪2.75 | 0.1% +₪99.2k | 37.3% | PE6.7x | |
| YBRD Y.B Urban Renewal - Residential Development | ₪6.15 | 0.02% +₪4.1k | -62.1% | PS47x |